CTI Life Sciences Fund L.P.

What is CTI Life Sciences Fund L.P.?

CTI Life Sciences Fund L.P. is a specialized venture capital firm focused on equity investments in the biotech, medical devices, and hospital services sectors, as well as oncology and investment management.

They possess expert knowledge in guiding companies from seed to startup and early-stage development.

Located at 1 Place Ville-Marie, Suite 1635, in Montreal, Quebec, they are a boutique firm known for making knowledge-driven decisions that catalyze emerging science, transform business objectives, and invest in scalable companies within Canada, the United States, and Europe. With the aim of delivering impactful innovations and strong returns to a broad array of stakeholders in the biotechnology and healthcare spaces, they consider themselves to be catalysts for transformative investments.

The CTI Life Sciences team comprises diverse professionals with deep scientific intelligence and business experience. With over 20 successful investments and 10 exits, including 3 FDA approvals, they leverage collective intelligence to drive significant results in life sciences. The managing partners each bring unique strengths, including comprehensive R&D experience in pharmaceuticals, expertise in mergers and acquisitions, asset licensing, and a proven track record in drug development to make informed investment decisions.

Committed to building strong companies, they apply a rigorous, all-inclusive approach to their investment decisions, ensuring they invest with confidence for the benefit of shareholders and patients alike. They are not simply investors, but rather partners in shaping innovative young businesses to achieve timely value inflection points and provide strategic guidance to cultivate growth and success.